Kolon Kanserleri
Synopsis
This chapter examines colon cancers, which are among the most common tumors of the gastrointestinal system and rank second in cancer-related mortality. Approximately 70% of colorectal cancers are sporadic, 20% are familial, and 10% develop due to hereditary syndromes such as FAP and Lynch syndrome. Environmental risk factors include high-calorie diets, red meat consumption, obesity, smoking, and alcohol use. Most cases arise from adenomatous polyps, where the histopathology (villous, tubulovillous, tubular) and polyp diameter directly influence malignant transformation risk. Genetic alterations in K-RAS and P53 play critical roles in carcinogenesis. The disease often remains asymptomatic initially, later presenting with localization-dependent clinical signs such as rectal bleeding, abdominal pain, iron deficiency anemia, and altered bowel habits. Diagnosis relies on physical examination, fecal occult blood tests, CEA levels, colonoscopy as the gold standard, and CT/MRI for staging and metastasis evaluation. Staging is based on the AJCC TNM classification system. Surgical management involves complete mesocolic or mesorectal excision, with a minimum recommendation of 12 resected lymph nodes for accurate staging. Stage-specific treatment ranges from endoscopic or segmental resection in Stages 0 and I to adjuvant chemotherapy in Stages II and III, while Stage IV utilizes surgery for select resectable metastases or palliative interventions.
References
Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017; 66: 683–691.
Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015; 385: 977–1010.
Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017; 18: e457–e471.
Jemal A, Siegel R, Ward E et al., “Cancer statistics, 2006. CA Cancer J Clin 2006; 56 (2):106–130.
Jorge JMN, Gama AH. Anatomy and Embryology of the Colon, Rectum and Anus In: Wolff BG, Fleshman JW, Beck DE, Pemberton JH, Wexner SD(Eds.). The ASCRS Textbook of Colon and Rectal Surgery 1 th Ed. USA: Springer; 2007:1–22
Guyton A., ed. Textbook of Medical Physiology. Philedelphia: WB Saunders; 1986:754–769.
Baykan A. , Zorluoğlu A. , Geçim E., Terzi C, Kolon ve Rektum Kanserleri 1 th Ed. İstanbul: Türk Kolon ve Rektum Cerrahisi Derneği: 2010
Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A., Primary Colon Cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2010; 21(5): 70-7.
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic Alterations during Colorectal Tumor development. New Engl J Med 1988; 319 (9):525–532.
Giovannucci E, Insulin and colon cancer. Cancer Causes Control 1995; 6(2): 164–179.
Yang YX, Hennessy S, Lewis JD, Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004; 127: 1044– 50 1050.
Sebastian S, Hernández V, Myrelid P, Kariv R, Tsianos E, Toruner M, Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I). Journal of Crohn’s and Colitis 2014; 8: 5–18.
Giovannucci E, Colditz GA, Stampfer MJ, A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993; 105(1):130–141.
Shao T, Yang Y, Cholecystectomy and the Risk of Colorectal Cancer. The American Journal of Gastroenterology 2005; 100: 1813–1820. https://www.nature.com/articles/ajg2005324.
Baxter NN, Tepper JE, Durham SB, Rothenberger DA, Virnig BA, “Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 2005; 128(4):819–824.
Boland CR., Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 2005; 4 (3): 211–218.
Boland CR., Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 2005; 4 (3): 211–218.
Fearon ER, Vogelstein B, . “A Genetic Model for Colorectal Tumorigenesis. Cell 1990;61 (5):759– 767.
Kumar V, Robbins S, Cotran R, “(Çeviri editörü: U. Çevikbaş). Temel Patoloji.7.edisyon. İstanbul: Nobel Tıp Kitabevleri; 2003; 579–588.
Mayer RJ., Gastrointestinal Tract Cancer. In Fauci AS, Kasper DL, Longo DL, et al, (eds). Harrison’s Principles of Internal Medicine. 17th edition, Chicago, The Mc Graw-Hill Companies, 2008; 570–580.
Ahnen DJ, Macrae FA, “Clinical Manifestations, Diagnosis, and Staging of Colorectal Cancer. Up ToDate, 2011(Ocak):1–32.
Göral, V., “Kolorektal Polipler ve Polipozis Sendromları. Içinde Tözün N, Şimşek H, Özkan H (yazarlar). Klinik Gastroenteroloji ve Hepatoloji. Ankara, MN Medikal & Nobel, 2007; 963–970.
Dubois R, Cecil Medicine. Tercüme: Ünal S, Kalyoncu U. Cecil Medicine 23. Baskı, Ankara, Güneş Tıp Kitabevleri, 2011;1469–1477.
Patricia AC, Tiffany OD, Alimantary Tract Cancers. In McPhee SJ, Papadakis MA, (eds). Current Medical Diagnosis & Treatment. 50th Anniversary Edition, Chicago, The Mc Graw-Hill Companies, 2011; 1547–1564.
Karahasanoğlu T, Kolorektal Kanserler: Tanı ve Cerrahi Tedavi. İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri. Gastrointestinal Sistem Hastalıkları Sempozyumu. İstanbul, 2001(Ocak):271–279.
Remzi FH Öncel M, Kolon Kanserinde Tarama ve Takip. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, 2006;17(1): 50–57.
Hekimoğlu ÖK Üstündağ Y, Kolorektal kanserlerde güncel radyolojik yaklaşımlar. Güncel Gastroenteroloji. 2007; 11(3): 154–159.
Perng S, A Decision Model for Colorectal Cancer Screening and Surveillance. Faculty of Purdue University, Master of Science, Indiana, 2010.
Cappell MS, Pathophysiology, clinical presentation, and management colon cancer. Gastroenterol Clin North Am. 2008; 37(1): 1–24.
Gollub MJ, Schwartz LH, Akhurst T, Date on colorectal cancer imaging. Radiol Clin North Am. 2007; 45(1):85–118.
Pijl ME, Chaoui AS, Wahl RL, Van Oostayen JA, Radiology of colorectal cancer.2002; 38(7):887–898.
Weber K, Göhl J, Lux P, Merkel S, Hohenberger W. [Principles and technique of lymph node dis section in colorectal carcinoma]. Der Chirurg. 2012;83(5):487- 498.
Culligan K, Coffey JC, Kiran RP, Kalady M, Lavery IC, Remzi FH. The mesocolon: a prospective observational study. Colorectal Disease. 2012;14(4):421-428. 99
Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue topelvic recurrence? British Journal of Surgery. 1982;69(10):613-616.
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. The Lancet. 1986;1(8496):1479-1482.
Heald RJ. The ‘Holy Plane’ of rectal surgery. Journal of the Royal Society of Medicine. 1988;81(9):503-508.
Gunderson LL, Sargent DJ, Tepper JE, O’Connell MJ, Allmer C, Smalley SR, Martenson JA, Haller DG, Mayer RJ, Rich TA, Ajani JA, Macdonald JS, Goldberg RM. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. International Journal of Radiation Oncology, Biology, Physics. 2002;54(2):386-396.
Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. Journal of Clinical Oncology. 2006;24(22):3570-3575.
American Joint Committee on Cancer. Colon and rectum. Philedelphia: Lippincott–Raven, 2002:113.